Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by 13C nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature

被引:60
作者
Aso, Y [1 ]
Yoshioka, S [1 ]
Kojima, S [1 ]
机构
[1] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 158, Japan
关键词
crystallization; molecular mobility; amorphous systems; relaxation time; glass transition temperature;
D O I
10.1002/jps.1033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To gain further insight into the effect of molecular mobility on the crystallization rate of amorphous drugs, the mean relaxation times of amorphous nifedipine and phenobarbital were calculated based on the Adam-Gibbs-Vogel (AGV) equation, using the parameters D, T-o, and T-f, derived from the heating rate dependence of the glass transition temperature (T-g) of the amorphous drug; and heat capacity of the drugs in the amorphous and crystalline states. These relaxation times were compared with the crystallization rate of amorphous nifedipine and phenobarbital reported previously. The spin-lattice relaxation time (T-1) and the spin-lattice relaxation time in the rotating frame (T-1 rho) of phenobarbital and nifedipine carbons were also determined. The temperature dependence of the crystallization rate of nifedipine and phenobarbital on the T-g was coincident with that of the mean relaxation time calculated according to the AGV equation within experimental error, indicating that the crystallization of nifedipine and phenobarbital is largely correlated with molecular mobility at the temperatures studied. A C-13 nuclear magnetic resonance relaxation study indicated that the molecular motion of nifedipine and phenobarbital in the mid-kHz frequency range became significant at temperatures higher than T-g- 20 and T-g, respectively, (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:798-806, 2001.
引用
收藏
页码:798 / 806
页数:9
相关论文
共 25 条
[1]   The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity [J].
Andronis, V ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 1998, 15 (06) :835-842
[2]  
Aso Y, 2000, J PHARM SCI, V89, P408, DOI 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO
[3]  
2-#
[4]   INTERACTION OF CALCIUM-CHANNEL ANTAGONISTS WITH CALCIUM - STRUCTURAL STUDIES ON NICARDIPINE AND ITS CA2+ COMPLEX [J].
BELCIUG, MP ;
ANANTHANARAYANAN, VS .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (25) :4392-4399
[5]   TRANSLATIONAL AND ROTATIONAL DIFFUSION IN SUPERCOOLED ORTHOTERPHENYL CLOSE TO THE GLASS-TRANSITION [J].
FUJARA, F ;
GEIL, B ;
SILLESCU, H ;
FLEISCHER, G .
ZEITSCHRIFT FUR PHYSIK B-CONDENSED MATTER, 1992, 88 (02) :195-204
[6]   NUCLEAR MAGNETIC-RESONANCE INVESTIGATIONS OF CALCIUM-ANTAGONIST DRUGS .1. CONFORMATIONAL AND DYNAMIC FEATURES OF NIMODIPINE (3-[(2-METHOXYETHOXY)CARBONYL]-5-(ISOPROPOXYCARBONYL)-4-(3-NITROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE)IN [H-2(6)]DIMETHYL SULFOXIDE [J].
GAGGELLI, E ;
MARCHETTINI, N ;
VALENSIN, G .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1987, (12) :1707-1711
[7]  
Guo YS, 2000, J PHARM SCI, V89, P128, DOI 10.1002/(SICI)1520-6017(200001)89:1<128::AID-JPS13>3.0.CO
[8]  
2-Z
[9]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12